Cell Signaling Technology, Inc.
32 Tozer Road
Beverly
Massachusetts
01915
United States
Tel: 978-927-5054
Fax: 978-922-7069
Website: http://www.cellsignal.com/
Email: info@cellsignal.com
34 articles about Cell Signaling Technology, Inc.
-
Bio-Techne and Cell Signaling Technology Announce Partnership to Validate Simple Western Antibodies
2/14/2023
Bio-Techne Corporation and Cell Signaling Technology announced the addition of Simple Western™ validation to CST antibodies.
-
CiteAb Names Cell Signaling Technology, “Antibody Company Of The Year” And “Researchers’ Choice”
2/11/2016
-
Cell Signaling Technology, Inc. Announces The Release Of Six New Monoclonal Antibodies For Tumor Immunology Research
11/4/2015
-
Cell Signaling Technology, Inc. Expands Portfolio With GMP Capabilities
10/13/2015
-
Cell Signaling Technology, Inc. Announces The Release Of A First To Market IHC-Approved VISTA Antibody
9/16/2015
-
Cell Signaling Technology, Inc. Announces PD-L1 Antibody, Important To Cancer Immunotherapy Research
4/7/2014
-
Cell Signaling Technology, Inc. Announces Introduction of Antibody Important to Breast Cancer Research
8/27/2013
-
Cell Signaling Technology, Inc. Announces License in Personalized Cancer Diagnostics
7/30/2013
-
Cell Signaling Technology, Inc. Awarded Patents Critical to Lung Cancer Therapy
7/9/2013
-
Cell Signaling Technology, Inc. Granted Patent for PCR Methods for Detection of a Subset of Treatable Non-Small Cell Lung Cancers
1/7/2013
-
Cell Signaling Technology, Inc. Develops Novel Monoclonal Antibody Discovery Platform
5/11/2012
-
Ventana Medical Systems, Inc. to Collaborate with Pfizer Inc. and Cell Signaling Technology, Inc. on Companion Diagnostic to Identify Lung Cancer Patients with ALK Gene Rearrangements
1/10/2012
-
Cell Signaling Technology, Inc. Wins Life Science Industry Awards in “Best Performing Antibodies” and “Best Breakthrough Products Cancer Research” Categories
12/5/2011
-
Cell Signaling Technology, Inc. Wins Life Science Industry Awards in “Best Performing Antibodies” and “Best Breakthrough Products Cancer Research” Categories
12/5/2011
-
Cell Signaling Technology, Inc. Grants a Patent License to Pfizer Inc.
7/6/2011
-
Cell Signaling Technology, Inc. Announces License in Personalized Cancer Diagnostics
3/15/2011
-
Cell Signaling Technology, Inc. Announces Joint Commercialization Partnership with Astellas Pharma Inc. in Cancer Personalized Medicine
2/23/2011
-
Cell Signaling Technology, Inc. Acquires BIOKE and Expands Operations to Europe
7/9/2009
-
Cell Signaling Technology, Inc. Announces Renewal of PhosphoScan(R) Proteomics Research Project for Lead Compound Biomarker Discovery
11/11/2008
-
Cell Signaling Technology, Inc. Expands Operations Overseas
4/9/2008